unknown
Stage
2
Investors
About
AN2 Therapeutics develops novel boron-based small molecule therapies targeting rare, chronic, and serious infectious diseases, hematology, and oncology conditions.
Explore AN2 Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.